Aaron Siri

Double is my understanding in terms of dollars. Don't quote me on this one, but you should look it up. I think last I heard, and this should be verified, double the next in line, which I thought was like oil and gas industry. So I don't know where trial lawyers stand in that thing, but I suspect those who would benefit from keeping that immunity probably have far more influence.

And that's probably why it stays in place.

And that's probably why it stays in place.

And that's probably why it stays in place.

The way that products get safer is the company's economic interest, which is a good thing, meaning their economic interest aligns with safety. I make a car. I make a drug. I want to make sure that it's as safe as I can make it so that I can still make money when I sell it and not face exposure downstream that will make me end up with a loss.

The way that products get safer is the company's economic interest, which is a good thing, meaning their economic interest aligns with safety. I make a car. I make a drug. I want to make sure that it's as safe as I can make it so that I can still make money when I sell it and not face exposure downstream that will make me end up with a loss.

The way that products get safer is the company's economic interest, which is a good thing, meaning their economic interest aligns with safety. I make a car. I make a drug. I want to make sure that it's as safe as I can make it so that I can still make money when I sell it and not face exposure downstream that will make me end up with a loss.

And they're given to only very small groups of people. So you have drugs given to small groups of people, like you said, and they can survive. But a product that you give to millions, often by coercion, by school mandates every single year, promoted by the federal government, you can't make a profit on. You don't have to pay a marketing budget because the government does it for you.

And they're given to only very small groups of people. So you have drugs given to small groups of people, like you said, and they can survive. But a product that you give to millions, often by coercion, by school mandates every single year, promoted by the federal government, you can't make a profit on. You don't have to pay a marketing budget because the government does it for you.

And they're given to only very small groups of people. So you have drugs given to small groups of people, like you said, and they can survive. But a product that you give to millions, often by coercion, by school mandates every single year, promoted by the federal government, you can't make a profit on. You don't have to pay a marketing budget because the government does it for you.

You don't have to worry about selling it, promoting it because they're mandating it to go to school. Millions have to take it. You're breaking in billions a year and you still can't turn a profit without the immunity? I mean, it's a very troubling reality. It's part of the reason that drove that petition.

You don't have to worry about selling it, promoting it because they're mandating it to go to school. Millions have to take it. You're breaking in billions a year and you still can't turn a profit without the immunity? I mean, it's a very troubling reality. It's part of the reason that drove that petition.

You don't have to worry about selling it, promoting it because they're mandating it to go to school. Millions have to take it. You're breaking in billions a year and you still can't turn a profit without the immunity? I mean, it's a very troubling reality. It's part of the reason that drove that petition.

I will give you, I'm going to put this into- How profitable, just to clear up something you said, how profitable are vaccines? The vaccine industry profits to the tune of billions of dollars a year.

I will give you, I'm going to put this into- How profitable, just to clear up something you said, how profitable are vaccines? The vaccine industry profits to the tune of billions of dollars a year.

I will give you, I'm going to put this into- How profitable, just to clear up something you said, how profitable are vaccines? The vaccine industry profits to the tune of billions of dollars a year.

Oh, absolutely. Oh my goodness. And since the early 80s, it is becoming an increasingly large percentage of their portfolio, in particular for Sanofi, Merck, GlaxoSmithKline, and Pfizer. Those four in particular make most of the childhood vaccines and vaccines in America.

Oh, absolutely. Oh my goodness. And since the early 80s, it is becoming an increasingly large percentage of their portfolio, in particular for Sanofi, Merck, GlaxoSmithKline, and Pfizer. Those four in particular make most of the childhood vaccines and vaccines in America.

Oh, absolutely. Oh my goodness. And since the early 80s, it is becoming an increasingly large percentage of their portfolio, in particular for Sanofi, Merck, GlaxoSmithKline, and Pfizer. Those four in particular make most of the childhood vaccines and vaccines in America.

And their portfolio, their percentage of portfolio has been increasing because imagine I came to you and I said, hey, Tucker, I got a business idea for you. Okay, you ready? You want to hear it? Listen to what we're going to do. We're going to put out this product, okay? Like, what is it? Don't worry about it. But we inject into people. Well, why would people take it?